Christine Coyne insider trades
Open-market stock purchases and sales by Christine Coyne, Chief Commercial Officer at Iterum Therapeutics plc, from SEC Form 4 filings since May 10, 2021.
Recent trades
No open-market trades in the last 12 months.
Open-market stock purchases and sales by Christine Coyne, Chief Commercial Officer at Iterum Therapeutics plc, from SEC Form 4 filings since May 10, 2021.
No open-market trades in the last 12 months.